Oral Peptide Drug - Global and China Top Players Market Share and Ranking 2025
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Oral Peptide Drug market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Oral Peptide Drug Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Oral Peptide Drug Market by Type [Analysis by Value from 2020 to 2031]:
- Linaclotide
- Insulin
- Plecanatide
- Cyclosporine
- Octreotide
Oral Peptide Drug Market by Application [Analysis by Value from 2020 to 2031]:
- Hospital
- Retail Pharmacy
Key Players in the Oral Peptide Drug Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
- Allergan
- Novo Nordisk
- Synergy Pharmaceuticals （Salix）
- Novartis
- Chiasma
Oral Peptide Drug Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Oral Peptide Drug Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Oral Peptide Drug Market Size & Demand Forecast (2031)
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Oral Peptide Drug Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Oral Peptide Drug Segmentation & Growth Forecasts
The study systematically breaks down the Global Oral Peptide Drug Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Oral Peptide Drug Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Oral Peptide Drug market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Oral Peptide Drug Definition
1.2 Global Oral Peptide Drug Market Size and Forecast
1.3 China Oral Peptide Drug Market Size and Forecast
1.4 Share of China Oral Peptide Drug Market with Respect to the Global Market
1.5 Oral Peptide Drug Market Size: China VS Global Growth Rate, 2020-2031
1.6 Oral Peptide Drug Market Dynamics
1.6.1 Oral Peptide Drug Market Drivers
1.6.2 Oral Peptide Drug Market Restraints
1.6.3 Oral Peptide Drug Industry Trends
1.6.4 Oral Peptide Drug Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Oral Peptide Drug, Global Market Share by Company, 2020-2025
2.2 Global Oral Peptide Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Oral Peptide Drug Concentration Ratio
2.4 Global Oral Peptide Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Oral Peptide Drug Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Oral Peptide Drug, China Market Share by Company, 2020-2025
3.2 China Oral Peptide Drug Oral Peptide Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Oral Peptide Drug Industry Chain
4.2 Oral Peptide Drug Upstream Analysis
4.2.1 Oral Peptide Drug Core Raw Materials
4.2.2 Main Manufacturers of Oral Peptide Drug Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Oral Peptide Drug Production Mode
4.6 Oral Peptide Drug Procurement Model
4.7 Oral Peptide Drug Industry Sales Model and Sales Channels
4.7.1 Oral Peptide Drug Sales Model
4.7.2 Oral Peptide Drug Typical Distributors
5 Sights by Type
5.1 Oral Peptide Drug Classification
5.1.1 Linaclotide
5.1.2 Insulin
5.1.3 Plecanatide
5.1.4 Cyclosporine
5.1.5 Octreotide
5.2 by Type, Global Oral Peptide Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Oral Peptide Drug Consumption Value, 2020-2031
6 Sights by Application
6.1 Oral Peptide Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.2 by Application, Global Oral Peptide Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Oral Peptide Drug Consumption Value, 2020-2031
7 Sales Sights by Region
7.1 By Region, Global Oral Peptide Drug Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Oral Peptide Drug Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Oral Peptide Drug Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Oral Peptide Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Oral Peptide Drug Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Oral Peptide Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Oral Peptide Drug Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Oral Peptide Drug Market Size Market Share
7.6 South America
7.6.1 South AmericaOral Peptide Drug Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Oral Peptide Drug Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Oral Peptide Drug Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Oral Peptide Drug Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Oral Peptide Drug Market Size, 2020-2031
8.3.2 by Type, United States Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Oral Peptide Drug Market Size, 2020-2031
8.4.2 by Type, Europe Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Oral Peptide Drug Market Size, 2020-2031
8.5.2 by Type, China Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Oral Peptide Drug Market Size, 2020-2031
8.6.2 by Type, Japan Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Oral Peptide Drug Market Size, 2020-2031
8.7.2 by Type, South Korea Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Oral Peptide Drug Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Oral Peptide Drug Market Size, 2020-2031
8.9.2 by Type, India Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Oral Peptide Drug Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
9 Company Profile
9.1 Allergan
9.1.1 Allergan Company Information, Head Office, Market Area, and Industry Position
9.1.2 Allergan Company Profile and Main Business
9.1.3 Allergan Oral Peptide Drug Models, Specifications, and Application
9.1.4 Allergan Oral Peptide Drug Revenue and Gross Margin, 2020-2025
9.1.5 Allergan Recent Developments
9.2 Novo Nordisk
9.2.1 Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
9.2.2 Novo Nordisk Company Profile and Main Business
9.2.3 Novo Nordisk Oral Peptide Drug Models, Specifications, and Application
9.2.4 Novo Nordisk Oral Peptide Drug Revenue and Gross Margin, 2020-2025
9.2.5 Novo Nordisk Recent Developments
9.3 Synergy Pharmaceuticals （Salix）
9.3.1 Synergy Pharmaceuticals （Salix） Company Information, Head Office, Market Area, and Industry Position
9.3.2 Synergy Pharmaceuticals （Salix） Company Profile and Main Business
9.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Drug Models, Specifications, and Application
9.3.4 Synergy Pharmaceuticals （Salix） Oral Peptide Drug Revenue and Gross Margin, 2020-2025
9.3.5 Synergy Pharmaceuticals （Salix） Recent Developments
9.4 Novartis
9.4.1 Novartis Company Information, Head Office, Market Area, and Industry Position
9.4.2 Novartis Company Profile and Main Business
9.4.3 Novartis Oral Peptide Drug Models, Specifications, and Application
9.4.4 Novartis Oral Peptide Drug Revenue and Gross Margin, 2020-2025
9.4.5 Novartis Recent Developments
9.5 Chiasma
9.5.1 Chiasma Company Information, Head Office, Market Area, and Industry Position
9.5.2 Chiasma Company Profile and Main Business
9.5.3 Chiasma Oral Peptide Drug Models, Specifications, and Application
9.5.4 Chiasma Oral Peptide Drug Revenue and Gross Margin, 2020-2025
9.5.5 Chiasma Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
List of Tables
Table 1. Oral Peptide Drug Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million
Table 2. Oral Peptide Drug Market Restraints
Table 3. Oral Peptide Drug Market Trends
Table 4. Oral Peptide Drug Industry Policy
Table 5. Global Oral Peptide Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 6. Global Oral Peptide Drug Revenue Share by Company, 2020-2025, Ranked by Data of 2024
Table 7. Global Oral Peptide Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Oral Peptide Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Oral Peptide Drug Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Oral Peptide Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024
Table 12. China Oral Peptide Drug Revenue Market Share by Company, 2020-2025
Table 13. Global Key Players of Oral Peptide Drug Upstream (Raw Materials)
Table 14. Global Oral Peptide Drug Typical Customers
Table 15. Oral Peptide Drug Typical Distributors
Table 16. by Type, Global Oral Peptide Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 17. by Application, Global Oral Peptide Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 18. By Region, Global Oral Peptide Drug Consumption Value, 2020 VS 2024 VS 2031, US$ Million
Table 19. By Region, Global Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Table 20. By Country, Global Oral Peptide Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million
Table 21. By Country, Global Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Table 22. By Country, Global Oral Peptide Drug Consumption Value Market Share, 2020-2031
Table 23. Allergan Company Information, Head Office, Market Area, and Industry Position
Table 24. Allergan Company Profile and Main Business
Table 25. Allergan Oral Peptide Drug Models, Specifications, and Application
Table 26. Allergan Oral Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025
Table 27. Allergan Recent Developments
Table 28. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
Table 29. Novo Nordisk Company Profile and Main Business
Table 30. Novo Nordisk Oral Peptide Drug Models, Specifications, and Application
Table 31. Novo Nordisk Oral Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025
Table 32. Novo Nordisk Recent Developments
Table 33. Synergy Pharmaceuticals （Salix） Company Information, Head Office, Market Area, and Industry Position
Table 34. Synergy Pharmaceuticals （Salix） Company Profile and Main Business
Table 35. Synergy Pharmaceuticals （Salix） Oral Peptide Drug Models, Specifications, and Application
Table 36. Synergy Pharmaceuticals （Salix） Oral Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025
Table 37. Synergy Pharmaceuticals （Salix） Recent Developments
Table 38. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 39. Novartis Company Profile and Main Business
Table 40. Novartis Oral Peptide Drug Models, Specifications, and Application
Table 41. Novartis Oral Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025
Table 42. Novartis Recent Developments
Table 43. Chiasma Company Information, Head Office, Market Area, and Industry Position
Table 44. Chiasma Company Profile and Main Business
Table 45. Chiasma Oral Peptide Drug Models, Specifications, and Application
Table 46. Chiasma Oral Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025
Table 47. Chiasma Recent Developments
List of Figures
Figure 1. Oral Peptide Drug Picture
Figure 2. Global Oral Peptide Drug Consumption Value, (US$ million) & (2020-2031)
Figure 3. China Oral Peptide Drug Consumption Value, (US$ million) & (2020-2031)
Figure 4. By Consumption Value, China Oral Peptide Drug Market Share of Global, 2020-2031
Figure 5. Global Oral Peptide Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024
Figure 6. China Oral Peptide Drug Key Participants, Market Share, 2024
Figure 7. Oral Peptide Drug Industry Chain
Figure 8. Oral Peptide Drug Procurement Model
Figure 9. Oral Peptide Drug Sales Model
Figure 10. Oral Peptide Drug Sales Channels, Direct Sales, and Distribution
Figure 11. Linaclotide
Figure 12. Insulin
Figure 13. Plecanatide
Figure 14. Cyclosporine
Figure 15. Octreotide
Figure 16. by Type, Global Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 17. by Type, Global Oral Peptide Drug Consumption Value Market Share, 2020-2031
Figure 18. Hospital
Figure 19. Retail Pharmacy
Figure 20. by Application, Global Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 21. by Application, Global Oral Peptide Drug Revenue Market Share, 2020-2031
Figure 22. By Region, Global Oral Peptide Drug Consumption Value Market Share, 2020-2031
Figure 23. North America Oral Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 24. By Country, North America Oral Peptide Drug Consumption Value Market Share, 2024
Figure 25. Europe Oral Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 26. By Country, Europe Oral Peptide Drug Consumption Value Market Share, 2024
Figure 27. Asia Pacific Oral Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 28. By Country/Region, Asia Pacific Oral Peptide Drug Consumption Value Market Share, 2024
Figure 29. South America Oral Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 30. By Country, South America Oral Peptide Drug Consumption Value Market Share, 2024
Figure 31. Middle East & Africa Oral Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million
Figure 32. United States Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 33. by Type, United States Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 34. by Application, United States Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 35. Europe Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 36. by Type, Europe Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 37. by Application, Europe Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 38. China Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 39. by Type, China Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 40. by Application, China Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 41. Japan Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 42. by Type, Japan Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 43. by Application, Japan Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 44. South Korea Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 45. by Type, South Korea Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 46. by Application, South Korea Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 47. Southeast Asia Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 48. by Type, Southeast Asia Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 49. by Application, Southeast Asia Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 50. India Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 51. by Type, India Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 52. by Application, India Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 53. Middle East & Africa Oral Peptide Drug Consumption Value, 2020-2031, US$ Million
Figure 54. by Type, Middle East & Africa Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 55. by Application, Middle East & Africa Oral Peptide Drug Consumption Value Market Share, 2024 VS 2031
Figure 56. Research Methodology
Figure 57. Breakdown of Primary Interviews
Figure 58. Bottom-up Approaches
Figure 59. Top-down Approaches
Research Methodology:
Oral Peptide Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|